Cancer Institute– A national cancer institute
designated cancer center

Nelson Teng

Back to Profile

Publication Details

  • Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?

    Zang RY, Li ZT, Tang J, Cheng X, Cai SM, Zhang ZY, Teng NN. Cancer. 2004; 100 (6): 1152-61

    This study was performed to address patient selection criteria and the role of secondary cytoreductive surgery (SCR) in patients with epithelial ovarian carcinoma (EOC) who had relapsed tumors after a progression-free interval > or = 3 months.

    PubMedID: 15022281

Stanford Medicine Resources:

Footer Links: